Muhammad Ahmad Nadeem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Ahmad Nadeem has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Abdul Rafeh Awan
Department of Surgery, Nishtar Medical University, Multan, Pakistan
6 shared publications - Amir Humza Sohail
Department of Surgery, University of New Mexico, Albuquerque, USA
6 shared publications Abu Baker Sheikh
Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA
4 shared publicationsAbdul Rafeh Awan
Nishtar Medical University, Multan, Pakistan
3 shared publicationsAbdullah Ahmad
Department of Medicine, CMH Lahore Medical College
3 shared publications- Abu Baker Sheikh
Department of Internal Medicine University of New Mexico Albuquerque New Mexico USA
3 shared publications
Latest Publications
- 27 August 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (6) , 965-977
Demographics and factors influencing mortality among cardiac angiosarcoma patients and genomic studies correlation for future personalized management
Cardiac angiosarcoma is an exceedingly rare and aggressive malignancy of the epithelial cells that line the blood vessels in cardiac tissue.1 It has an incidence rate of approximately 0.017%, most ...
- 27 August 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (6) , 965-977
Demographics and factors influencing mortality among cardiac angiosarcoma patients and genomic studies correlation for future personalized management
Cardiac angiosarcoma is an exceedingly rare and aggressive malignancy of the epithelial cells that line the blood vessels in cardiac tissue.1 It has an incidence rate of approximately 0.017%, most ...
- Open Access
- 26 August 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14931-14933
Response to “Letter to the Editor: liver transplantation for colorectal metastasis – selection criteria, outcomes, and management recurrence: a systematic review and meta-analysis”
Was not provided for this article.
- 26 August 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (11) , 14931-14933
Open AccessResponse to “Letter to the Editor: liver transplantation for colorectal metastasis – selection criteria, outcomes, and management recurrence: a systematic review and meta-analysis”
Was not provided for this article.
- 7 July 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (5) , 1-9
Young-onset signet ring cell colorectal adenocarcinoma: demographics, clinicopathological profile, and survival analysis
Signet ring cell carcinoma (SRCC), a rare subtype of colorectal adenocarcinoma, is associated with high rates of metastasis at presentation and poor prognosis. This study highlights demographic patterns, survival outcomes, and prognostic factors in young-onset SRCC. A retrospective analysis of SRCC patients P < 0.001). Colorectal SRCC is an aggressive malignancy that disproportionately affects patients <50 years and frequently presents at advanced stages, underscoring the importance of earlier screening.
- 7 July 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (5) , 1-9
Young-onset signet ring cell colorectal adenocarcinoma: demographics, clinicopathological profile, and survival analysis
Signet ring cell carcinoma (SRCC), a rare subtype of colorectal adenocarcinoma, is associated with high rates of metastasis at presentation and poor prognosis. This study highlights demographic patterns, survival outcomes, and prognostic factors in young-onset SRCC. A retrospective analysis of SRCC patients P < 0.001). Colorectal SRCC is an aggressive malignancy that disproportionately affects patients <50 years and frequently presents at advanced stages, underscoring the importance of earlier screening.
- 4 June 2026
- Published by Wolters Kluwer Health in Pancreas
- Vol. 55 (8) , e810-e817
Trends in Pancreatic Cancer Incidence, Prevalence, and Mortality in the United States and High SDI Countries (1991–2021) and Future Projections: A Forecasting Population-Based Analysis
Objectives: Pancreatic cancer has poor prognosis and incidence is rising, particularly in high Socio-Demographic Index (SDI) countries. This study examines trends in pancreatic cancer incidence, prevalence, and mortality in the US and high SDI countries from 1991 to 2021 and uses modeling to project pancreatic cancer rates through 2041. Methods: This retrospective, population-based observational study analyzed pancreatic cancer trends using the Global Burden of Disease (GBD) database. Primary outcome measures included age-standardized incidence (ASIR), prevalence (ASPR), and mortality (ASMR) rates, stratified by sex and region. Joinpoint regression analysis estimated annual percentage change (APC) with 95% confidence intervals (CIs) to identify significant trends. Autoregressive Integrated Moving Average (ARIMA) models were used to forecast rates from 2022-2041. Results: From 1991 to 2021, pancreatic cancer ASIR, ASPR, and ASMR rose in both the US and high-SDI countries, with a sharp rise after 2001 and a plateau after 2016. ASIR peaked at 10.46 (US, 2016) and 10.24 (high SDI, 2018), with similar trends in ASPR and ASMR. APC analysis revealed a significant rise (p<0.001) in most periods through 2016, though rates recently declined between 2016–2020. Males consistently had higher rates compared to females. Projections of ASMR to 2041 continue to rise to 9.856 in high SDI countries and 9.813 in the US, leading to a projected 271,310 and 72,304 deaths, respectively. Conclusions: Pancreatic cancer incidence, prevalence and mortality have increased in the past two decades in both high SDI countries and the US. Rising incidence and prevalence are likely driven by a combination of improved diagnosis and treatment, as well as population aging, lifestyle, and environmental factors. Males have higher rates compared to females across both regions, a trend that has not yet been fully explained. Despite the recent stabilization of pancreatic cancer rates, modeling predicts a rise in all three metrics through 2041. Continued efforts are imperative to refine early diagnostic methods, identify modifiable risk factors, and develop effective interventions to reduce mortality.
- 4 June 2026
- Published by Wolters Kluwer Health in Pancreas
- Vol. 55 (8) , e810-e817
Trends in Pancreatic Cancer Incidence, Prevalence, and Mortality in the United States and High SDI Countries (1991–2021) and Future Projections: A Forecasting Population-Based Analysis
Objectives: Pancreatic cancer has poor prognosis and incidence is rising, particularly in high Socio-Demographic Index (SDI) countries. This study examines trends in pancreatic cancer incidence, prevalence, and mortality in the US and high SDI countries from 1991 to 2021 and uses modeling to project pancreatic cancer rates through 2041. Methods: This retrospective, population-based observational study analyzed pancreatic cancer trends using the Global Burden of Disease (GBD) database. Primary outcome measures included age-standardized incidence (ASIR), prevalence (ASPR), and mortality (ASMR) rates, stratified by sex and region. Joinpoint regression analysis estimated annual percentage change (APC) with 95% confidence intervals (CIs) to identify significant trends. Autoregressive Integrated Moving Average (ARIMA) models were used to forecast rates from 2022-2041. Results: From 1991 to 2021, pancreatic cancer ASIR, ASPR, and ASMR rose in both the US and high-SDI countries, with a sharp rise after 2001 and a plateau after 2016. ASIR peaked at 10.46 (US, 2016) and 10.24 (high SDI, 2018), with similar trends in ASPR and ASMR. APC analysis revealed a significant rise (p<0.001) in most periods through 2016, though rates recently declined between 2016–2020. Males consistently had higher rates compared to females. Projections of ASMR to 2041 continue to rise to 9.856 in high SDI countries and 9.813 in the US, leading to a projected 271,310 and 72,304 deaths, respectively. Conclusions: Pancreatic cancer incidence, prevalence and mortality have increased in the past two decades in both high SDI countries and the US. Rising incidence and prevalence are likely driven by a combination of improved diagnosis and treatment, as well as population aging, lifestyle, and environmental factors. Males have higher rates compared to females across both regions, a trend that has not yet been fully explained. Despite the recent stabilization of pancreatic cancer rates, modeling predicts a rise in all three metrics through 2041. Continued efforts are imperative to refine early diagnostic methods, identify modifiable risk factors, and develop effective interventions to reduce mortality.
- Open Access
- 6 May 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (6) , e1955
The Impact of Normothermic Machine Liver Perfusion on Early Renal Outcomes After Simultaneous Liver-kidney Transplantation: A Propensity Score–Matched Analysis
Background.: No study has assessed the effect of end-ischemic normothermic machine perfusion (NMP) on renal function in simultaneous liver-kidney (SLK) transplantation. We hypothesized that by mitigating liver ischemia/reperfusion injury, NMP exerts a renoprotective effect on kidney allografts. This study compares renal outcomes in SLK transplant recipients receiving NMP versus static cold storage (SCS) livers. Methods.: We analyzed deceased-donor SLK transplant recipients (January 2019–July 2024) with at least 6 mo follow-up (n = 85). Primary outcomes included delayed graft function (DGF) and functional-DGF (f-DGF; failure of serum creatinine to decrease 10% daily for 3 d in the first week). Liver Core Outcome Sets were reported. NMP recipients (n = 17) were propensity score–matched 1:2 to SCS controls (n = 34). Kidneys underwent hypothermic machine perfusion in both groups. Results.: Cohorts were well matched, although NMP had more donation after circulatory death donors ( P = 0.006). f-DGF was significantly lower in NMP versus SCS (35% versus 68%, P = 0.025); this persisted in the hepatorenal syndrome subcohort (27% versus 65%, P = 0.03). Post–reperfusion syndrome was lower in NMP ( P = 0.041). NMP demonstrated superior renal function: lower peak creatinine (2.58 versus 3.03 mg/dL, P = 0.031), higher lowest postoperative estimated glomerular filtration rate (25 versus 19 mL/min/1.73 m 2 , P = 0.021), and reduced 6-mo dialysis requirement (6% versus 32%, P = 0.036). Conclusions.: In this cohort, NMP was associated with improved early renal recovery in SLK transplant recipients, characterized by lower rates of f-DGF and higher estimated glomerular filtration rate. These findings suggest that mitigating liver ischemia via NMP may provide secondary benefits to the simultaneous kidney allograft.
- 6 May 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (6) , e1955
Open AccessThe Impact of Normothermic Machine Liver Perfusion on Early Renal Outcomes After Simultaneous Liver-kidney Transplantation: A Propensity Score–Matched Analysis
Background.: No study has assessed the effect of end-ischemic normothermic machine perfusion (NMP) on renal function in simultaneous liver-kidney (SLK) transplantation. We hypothesized that by mitigating liver ischemia/reperfusion injury, NMP exerts a renoprotective effect on kidney allografts. This study compares renal outcomes in SLK transplant recipients receiving NMP versus static cold storage (SCS) livers. Methods.: We analyzed deceased-donor SLK transplant recipients (January 2019–July 2024) with at least 6 mo follow-up (n = 85). Primary outcomes included delayed graft function (DGF) and functional-DGF (f-DGF; failure of serum creatinine to decrease 10% daily for 3 d in the first week). Liver Core Outcome Sets were reported. NMP recipients (n = 17) were propensity score–matched 1:2 to SCS controls (n = 34). Kidneys underwent hypothermic machine perfusion in both groups. Results.: Cohorts were well matched, although NMP had more donation after circulatory death donors ( P = 0.006). f-DGF was significantly lower in NMP versus SCS (35% versus 68%, P = 0.025); this persisted in the hepatorenal syndrome subcohort (27% versus 65%, P = 0.03). Post–reperfusion syndrome was lower in NMP ( P = 0.041). NMP demonstrated superior renal function: lower peak creatinine (2.58 versus 3.03 mg/dL, P = 0.031), higher lowest postoperative estimated glomerular filtration rate (25 versus 19 mL/min/1.73 m 2 , P = 0.021), and reduced 6-mo dialysis requirement (6% versus 32%, P = 0.036). Conclusions.: In this cohort, NMP was associated with improved early renal recovery in SLK transplant recipients, characterized by lower rates of f-DGF and higher estimated glomerular filtration rate. These findings suggest that mitigating liver ischemia via NMP may provide secondary benefits to the simultaneous kidney allograft.
- 23 December 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (1) , 48-56
Temporal analysis of sickle cell disease mortality in adults (1999–2020): insights from the CDC WONDER database
This study aimed to evaluate temporal trends in adult sickle cell disease (SCD) mortality in the United States from 1999 to 2020, stratified by age, sex, race, and geography, to identify disparities and guide targeted interventions. A retrospective observational study was conducted using national mortality data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) database. The sample included adults aged ≥15 years who died from SCD between 1999 and 2020 (n = 17,443). Age-adjusted mortality rates (AAMRs) were calculated and stratified by demographic and geographic variables. Temporal trends were assessed using Mann-Kendall trend tests, and t-tests were applied to compare continuous variables across subgroups. Statistical significance was defined as P < 0.05. The AAMR for adult SCD increased by 132% over the study period (P = 0.014). The greatest rise in mortality was observed among adults aged ≥65 years (P = 0.008) and women (P = 0.015). Black individuals accounted for 97.5% of SCD-related deaths, underscoring severe racial disparities. Geographically, the Southern region exhibited the highest AAMR and was the only region with a statistically significant increase in mortality over time (P = 0.001). Adult SCD mortality in the United States has risen significantly from 1999 to 2020, with disproportionate increases among older adults, women, and individuals in the Southern region. The findings highlight urgent needs for targeted national interventions, development of age-specific care models, and implementation of equity-focused health policies to address persistent racial and regional disparities in SCD outcomes.
- 23 December 2025
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- Vol. 39 (1) , 48-56
Temporal analysis of sickle cell disease mortality in adults (1999–2020): insights from the CDC WONDER database
This study aimed to evaluate temporal trends in adult sickle cell disease (SCD) mortality in the United States from 1999 to 2020, stratified by age, sex, race, and geography, to identify disparities and guide targeted interventions. A retrospective observational study was conducted using national mortality data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) database. The sample included adults aged ≥15 years who died from SCD between 1999 and 2020 (n = 17,443). Age-adjusted mortality rates (AAMRs) were calculated and stratified by demographic and geographic variables. Temporal trends were assessed using Mann-Kendall trend tests, and t-tests were applied to compare continuous variables across subgroups. Statistical significance was defined as P < 0.05. The AAMR for adult SCD increased by 132% over the study period (P = 0.014). The greatest rise in mortality was observed among adults aged ≥65 years (P = 0.008) and women (P = 0.015). Black individuals accounted for 97.5% of SCD-related deaths, underscoring severe racial disparities. Geographically, the Southern region exhibited the highest AAMR and was the only region with a statistically significant increase in mortality over time (P = 0.001). Adult SCD mortality in the United States has risen significantly from 1999 to 2020, with disproportionate increases among older adults, women, and individuals in the Southern region. The findings highlight urgent needs for targeted national interventions, development of age-specific care models, and implementation of equity-focused health policies to address persistent racial and regional disparities in SCD outcomes.
- Open Access
- 13 November 2025
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 61 (1) , 1-15
Diagnostic accuracy of anti-integrin αvβ6 in ulcerative colitis: a diagnostic meta-analysis
Background: Ulcerative colitis (UC) presents with diagnostic challenges due to symptom overlap with other gastrointestinal (GI) disorders. Recent studies identify anti-integrin αvβ6 autoantibodies as a promising biomarker for UC. This meta-analysis aims to evaluate the diagnostic accuracy of anti-integrin αvβ6 antibodies in distinguishing UC from healthy individuals and other GI diseases. Methods: We conducted a systematic literature search of PubMed, Scopus, and Embase up to February, 2025, following PRISMA guidelines. Studies assessing the diagnostic performance of anti-integrin αvβ6 antibodies in UC patients were included. A bivariate random-effects model was used to pool sensitivity and specificity estimates using STATA. Forest plots and SROC curves were generated. Meta-regression and interaction analyses explored the influence of covariates such as control group type, age group, and geographic region on diagnostic performance. Risk of bias was assessed using tool QUADAS-2. Post hoc analyses were conducted to assess the impact of cut-off thresholds and ELISA platforms on the diagnostic performance of anti-integrin αvβ6 antibodies. Results: Six studies comprising 3887 participants (1904 UC patients) were included in meta-analysis. The pooled sensitivity and specificity of anti-integrin αvβ6 for UC across all comparator groups were 83% (95% CI: 0.70–0.91) and 93% (95% CI: 0.88–0.97), respectively. Diagnostic performance remained consistent across control types for sensitivity but varied significantly for specificity, especially when Crohn’s disease was used as a comparator (81%; 95% CI: 0.75–0.86). Multivariate meta-regression identified patient age, geographic region, and control group type as significant modifiers of specificity. Interaction models further confirmed a combined influence of these factors on diagnostic performance. Post hoc analyses revealed that sensitivity remained stable across thresholds (2SD: 0.65, 3SD: 0.87), while specificity varied significantly depending on cut-off values (2SD: 0.89, 3SD: 0.92) and ELISA methodology (0.92 vs. 0.83). Conclusions: Our meta-analysis demonstrates that anti-integrin αvβ6 antibodies exhibit high diagnostic accuracy for UC, with consistent sensitivity and specificity. Their performance is influenced by patient demographics and study region, suggesting the need for tailored diagnostic criteria in clinical settings.
- 13 November 2025
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 61 (1) , 1-15
Open AccessDiagnostic accuracy of anti-integrin αvβ6 in ulcerative colitis: a diagnostic meta-analysis
Background: Ulcerative colitis (UC) presents with diagnostic challenges due to symptom overlap with other gastrointestinal (GI) disorders. Recent studies identify anti-integrin αvβ6 autoantibodies as a promising biomarker for UC. This meta-analysis aims to evaluate the diagnostic accuracy of anti-integrin αvβ6 antibodies in distinguishing UC from healthy individuals and other GI diseases. Methods: We conducted a systematic literature search of PubMed, Scopus, and Embase up to February, 2025, following PRISMA guidelines. Studies assessing the diagnostic performance of anti-integrin αvβ6 antibodies in UC patients were included. A bivariate random-effects model was used to pool sensitivity and specificity estimates using STATA. Forest plots and SROC curves were generated. Meta-regression and interaction analyses explored the influence of covariates such as control group type, age group, and geographic region on diagnostic performance. Risk of bias was assessed using tool QUADAS-2. Post hoc analyses were conducted to assess the impact of cut-off thresholds and ELISA platforms on the diagnostic performance of anti-integrin αvβ6 antibodies. Results: Six studies comprising 3887 participants (1904 UC patients) were included in meta-analysis. The pooled sensitivity and specificity of anti-integrin αvβ6 for UC across all comparator groups were 83% (95% CI: 0.70–0.91) and 93% (95% CI: 0.88–0.97), respectively. Diagnostic performance remained consistent across control types for sensitivity but varied significantly for specificity, especially when Crohn’s disease was used as a comparator (81%; 95% CI: 0.75–0.86). Multivariate meta-regression identified patient age, geographic region, and control group type as significant modifiers of specificity. Interaction models further confirmed a combined influence of these factors on diagnostic performance. Post hoc analyses revealed that sensitivity remained stable across thresholds (2SD: 0.65, 3SD: 0.87), while specificity varied significantly depending on cut-off values (2SD: 0.89, 3SD: 0.92) and ELISA methodology (0.92 vs. 0.83). Conclusions: Our meta-analysis demonstrates that anti-integrin αvβ6 antibodies exhibit high diagnostic accuracy for UC, with consistent sensitivity and specificity. Their performance is influenced by patient demographics and study region, suggesting the need for tailored diagnostic criteria in clinical settings.
- 3 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-15
Da Vinci Xi versus laparoscopic transabdominal preperitoneal (TAPP) repair of inguinal hernia: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Transabdominal preperitoneal (TAPP) repair is the gold standard for minimally invasive inguinal hernia surgery. With the advent of robotic surgery, robotic-assisted TAPP (r-TAPP) has emerged as an alternative to conventional laparoscopic TAPP (l-TAPP), although comparative evidence remains limited. We conducted a prospectively registered systematic review and meta-analysis (PROSPERO ID: CRD420251154089) of randomized controlled trials comparing r-TAPP and l-TAPP in adults with inguinal hernias. We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and Google Scholar from inception to September 2025 for relevant studies. The primary outcomes were operative duration and postoperative complications within 30 days. The secondary outcomes included seroma, hematoma, urinary retention, and readmission rates. A random-effects meta-analysis was performed using RevMan 5.4. Evidence certainty was assessed using the GRADE methodology. Three randomized controlled trials encompassing 379 patients (196 r-TAPP and 183 l-TAPP) met the inclusion criteria. Overall operative time showed no significant difference (MD 0.59 min, 95% CI -23.67 to 24.85, I²=98%). However, sensitivity analysis removing the heterogeneity-driving study revealed r-TAPP advantage (-15.20 min, 95% CI -18.58 to -11.82, p < 0.00001). No statistically significant differences were observed for any postoperative complication (OR 0.84, 95% CI 0.19–3.79), seroma (OR 1.00, 95% CI 0.13–8.01), hematoma (OR 0.64, 95% CI 0.08–5.30), urinary retention (OR 0.55, 95% CI 0.17–1.76), or readmission (OR 0.51, 95% CI 0.02–12.14). GRADE certainty ranged from low to very low because of imprecision and inconsistency. Across three randomized trials, r-TAPP and l-TAPP showed similar short-term safety with no confirmed difference in operative time. Substantial heterogeneity—likely related to trial design and experience—limits certainty, and publication bias cannot be reliably assessed with so few studies. Larger, multicenter RCTs with standardized protocols and definitions are needed to establish comparative effectiveness.
- 3 November 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-15
Da Vinci Xi versus laparoscopic transabdominal preperitoneal (TAPP) repair of inguinal hernia: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Transabdominal preperitoneal (TAPP) repair is the gold standard for minimally invasive inguinal hernia surgery. With the advent of robotic surgery, robotic-assisted TAPP (r-TAPP) has emerged as an alternative to conventional laparoscopic TAPP (l-TAPP), although comparative evidence remains limited. We conducted a prospectively registered systematic review and meta-analysis (PROSPERO ID: CRD420251154089) of randomized controlled trials comparing r-TAPP and l-TAPP in adults with inguinal hernias. We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and Google Scholar from inception to September 2025 for relevant studies. The primary outcomes were operative duration and postoperative complications within 30 days. The secondary outcomes included seroma, hematoma, urinary retention, and readmission rates. A random-effects meta-analysis was performed using RevMan 5.4. Evidence certainty was assessed using the GRADE methodology. Three randomized controlled trials encompassing 379 patients (196 r-TAPP and 183 l-TAPP) met the inclusion criteria. Overall operative time showed no significant difference (MD 0.59 min, 95% CI -23.67 to 24.85, I²=98%). However, sensitivity analysis removing the heterogeneity-driving study revealed r-TAPP advantage (-15.20 min, 95% CI -18.58 to -11.82, p < 0.00001). No statistically significant differences were observed for any postoperative complication (OR 0.84, 95% CI 0.19–3.79), seroma (OR 1.00, 95% CI 0.13–8.01), hematoma (OR 0.64, 95% CI 0.08–5.30), urinary retention (OR 0.55, 95% CI 0.17–1.76), or readmission (OR 0.51, 95% CI 0.02–12.14). GRADE certainty ranged from low to very low because of imprecision and inconsistency. Across three randomized trials, r-TAPP and l-TAPP showed similar short-term safety with no confirmed difference in operative time. Substantial heterogeneity—likely related to trial design and experience—limits certainty, and publication bias cannot be reliably assessed with so few studies. Larger, multicenter RCTs with standardized protocols and definitions are needed to establish comparative effectiveness.
- Open Access
- 14 October 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 593-607
Trends in Mortality-Related to Peripheral Artery Disease and Chronic Obstructive Pulmonary Disease Comorbidity in the United States (1999–2023)
- 14 October 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 593-607
Open AccessTrends in Mortality-Related to Peripheral Artery Disease and Chronic Obstructive Pulmonary Disease Comorbidity in the United States (1999–2023)
- 11 October 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-16
Da Vinci-assisted vs laparoscopic nissen fundoplication for GERD: a systematic review and meta-analysis of randomized controlled trials on patient-reported outcomes, dysphagia, and long-term failure
The comparative effectiveness of da Vinci robot-assisted versus conventional laparoscopic Nissen fundoplication for gastroesophageal reflux disease remains controversial despite increasing adoption of robotic platforms. Previous meta-analyses have yielded conflicting results regarding patient-centered outcomes and long-term durability. We conducted a systematic review and meta-analysis of randomized controlled trials comparing da Vinci-assisted versus conventional laparoscopic Nissen fundoplication. This review was prospectively registered with PROSPERO (CRD420251139110). We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and grey literature sources through August 2025. Primary outcomes included postoperative dysphagia, proton pump inhibitor use, and intraoperative complications. Secondary outcomes encompassed reoperation rates, operative time, length of stay, and conversion to open surgery. Risk ratios and mean differences were calculated using random-effects models. Evidence certainty was assessed using the GRADE methodology. Four randomized controlled trials involving 160 patients (79 robotic, 81 conventional laparoscopic) met the inclusion criteria. No significant differences were observed in early dysphagia (RR 1.05, 95% CI 0.45–2.45), postoperative proton pump inhibitor use (RR 0.97, 95% CI 0.25–3.79), or intraoperative complications (RR 0.43, 95% CI 0.07–2.81). Secondary outcomes showed no differences in reoperation rates (RR 1.65, 95% CI 0.40–6.90), length of hospital stay (MD -0.03 days, 95% CI -0.41 to 0.36), or conversion rates (RR 1.23, 95% CI 0.19–7.99). Operative time demonstrated substantial heterogeneity; sensitivity analysis revealed significantly longer times with robotics when one outlier study was removed (MD 40.28 min, p < 0.00001). Da Vinci robot-assisted and conventional laparoscopic Nissen fundoplication achieve equivalent clinical outcomes with no significant differences in patient-reported outcomes, complications, or long-term effectiveness, while robotic procedures consistently require longer operative times and substantially higher costs without demonstrable clinical benefits. These findings question the routine application of robotic platforms in antireflux surgery until cost-effectiveness and operative efficiency are optimized.
- 11 October 2025
- Published by Springer Nature in Journal of Robotic Surgery
- Vol. 19 (1) , 1-16
Da Vinci-assisted vs laparoscopic nissen fundoplication for GERD: a systematic review and meta-analysis of randomized controlled trials on patient-reported outcomes, dysphagia, and long-term failure
The comparative effectiveness of da Vinci robot-assisted versus conventional laparoscopic Nissen fundoplication for gastroesophageal reflux disease remains controversial despite increasing adoption of robotic platforms. Previous meta-analyses have yielded conflicting results regarding patient-centered outcomes and long-term durability. We conducted a systematic review and meta-analysis of randomized controlled trials comparing da Vinci-assisted versus conventional laparoscopic Nissen fundoplication. This review was prospectively registered with PROSPERO (CRD420251139110). We searched MEDLINE, Embase, Cochrane CENTRAL, Web of Science, Scopus, ClinicalTrials.gov, WHO ICTRP, and grey literature sources through August 2025. Primary outcomes included postoperative dysphagia, proton pump inhibitor use, and intraoperative complications. Secondary outcomes encompassed reoperation rates, operative time, length of stay, and conversion to open surgery. Risk ratios and mean differences were calculated using random-effects models. Evidence certainty was assessed using the GRADE methodology. Four randomized controlled trials involving 160 patients (79 robotic, 81 conventional laparoscopic) met the inclusion criteria. No significant differences were observed in early dysphagia (RR 1.05, 95% CI 0.45–2.45), postoperative proton pump inhibitor use (RR 0.97, 95% CI 0.25–3.79), or intraoperative complications (RR 0.43, 95% CI 0.07–2.81). Secondary outcomes showed no differences in reoperation rates (RR 1.65, 95% CI 0.40–6.90), length of hospital stay (MD -0.03 days, 95% CI -0.41 to 0.36), or conversion rates (RR 1.23, 95% CI 0.19–7.99). Operative time demonstrated substantial heterogeneity; sensitivity analysis revealed significantly longer times with robotics when one outlier study was removed (MD 40.28 min, p < 0.00001). Da Vinci robot-assisted and conventional laparoscopic Nissen fundoplication achieve equivalent clinical outcomes with no significant differences in patient-reported outcomes, complications, or long-term effectiveness, while robotic procedures consistently require longer operative times and substantially higher costs without demonstrable clinical benefits. These findings question the routine application of robotic platforms in antireflux surgery until cost-effectiveness and operative efficiency are optimized.